UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials

Pharmacological research, 2020-10, Vol.160, p.105060-105060, Article 105060

2020

Volltextzugriff (PDF)

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group

Frontiers in genetics, 2023-04, Vol.14, p.1113454-1113454

2023

Volltextzugriff (PDF)

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

European journal of preventive cardiology, 2022-05, Vol.29 (5), p.804

2022

Volltextzugriff (PDF)

Heterogeneity of the genetic background and phenotypic expression of familial hypercholesterolaemia in two cohorts from Italy and Russia

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN)

Journal of internal medicine, 2022-05, Vol.291 (5), p.702-704

2022

Volltextzugriff (PDF)

Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries

European journal of internal medicine, 2024-05, Vol.123, p.65-71

2024

Volltextzugriff (PDF)

Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis

Journal of clinical lipidology, 2021-11, Vol.15 (6), p.822-831

2021

Volltextzugriff (PDF)

Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

Atherosclerosis, 2022-05, Vol.349, p.233-239

2022

Volltextzugriff (PDF)

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry

European journal of preventive cardiology, 2024-06, Vol.31 (8), p.1038

2024

Volltextzugriff (PDF)

Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

Nutrients, 2023-08, Vol.15 (15), p.3468

2023

Volltextzugriff (PDF)

Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations

Journal of the American Heart Association, 2022-04, Vol.11 (7), p.e023668-e023668

2022

Volltextzugriff (PDF)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

Journal of the American Heart Association, 2023-05, Vol.12 (10), p.e029223-e029223

2023

Volltextzugriff (PDF)

How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia

Atherosclerosis. Supplements, 2020-12, Vol.42, p.e35-e40

2020

Volltextzugriff (PDF)

Synthesis and Characterization of Curcumin-Loaded Nanoparticles of Poly(Glycerol Sebacate): A Novel Highly Stable Anticancer System

Molecules (Basel, Switzerland), 2022-10, Vol.27 (20), p.6997

2022

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

Heterogeneity of the genetic background and phenotypic expression of familial hypercholesterolaemia in two cohorts from Italy and Russia

Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN)

Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries

Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis

Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry

Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia

Synthesis and Characterization of Curcumin-Loaded Nanoparticles of Poly(Glycerol Sebacate): A Novel Highly Stable Anticancer System

Suchergebnisse filtern